Search
for
Sort by
Research 91–120 of 1000+
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- “Occult” ovarian Leydig cell tumor: when laboratory tells more than imaging
- Skin manifestations of endocrine diseases
- Antiandrogen Therapy for Skin and Hair Disease
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Polycystic Ovary Syndrome in Adolescents
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications
- Gene expression of type 2 17β hydroxysteroid dehydrogenase in scalp hairs of hirsute women
- The rationale for physiological testosterone replacement in women
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Hirsutism – From Diagnosis to Use of Antiandrogens
- Suety and Spreading-Stromal Hyperplasia and Hyperthecosis Ovary
- Challenges in diagnosing ovarian sertoli-leydig cell tumors: A Peruvian case series
- Selected Disorders of Skin Appendages—Acne, Alopecia, Hyperhidrosis
- Hirsutism and virilization
- Sex hormones and related compounds, including hormonal contraceptives
- Baldness, acne and testicular germ cell tumours
- Histopathological Findings and Proliferative Activity of Canine Sebaceous Gland Tumours with a Predominant Reserve Cell Population
- Steroid Hormones of Reproduction and Sexual Development
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- A review of diagnosis and treatment of acne in adult female patients
- Menopausal Acne – Challenges And Solutions
- Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica
- Polycystic ovary syndrome: An update on diagnosis and management
- Acne, the Skin Microbiome, and Antibiotic Treatment
- Adrenal Disorders and the Paediatric Brain: Pathophysiological Considerations and Clinical Implications
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)